1-11 of 11
Jie He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer

Christopher J. Sweeney, Russell Petry, Chang Xu, Merrida Childress, Jie He, David Fabrizio, Ole Gjoerup, Samantha Morley, Timothy Catlett, Zoe J. Assaf, Kobe Yuen, Matthew Wongchenko, Kalpit Shah, Pratyush Gupta, Priti Hegde, Lincoln W. Pasquina, Sanjeev Mariathasan, Ryon P. Graf, Thomas Powles
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF8.
https://doi.org/10.1158/1078-0432.CCR-24-1096
Published: 06 August 2024
View article titled, Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma

Tiansuo Zhao, Tingting Jiang, Xiaojia Li, Shaofei Chang, Qihui Sun, Fanyang Kong, Xiangyu Kong, Fang Wei, Jie He, Jihui Hao, Keping Xie
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (24): 5183–5195.
https://doi.org/10.1158/1078-0432.CCR-23-1143
Published: 15 December 2023
View article titled, Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma
Open the PDF for Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates

Fang Wei, Yuling Su, Yibo Quan, Xiaojia Li, Qi Zou, Liuxi Zhang, Shu Li, Mengmeng Jiang, Guohuan Lin, Ping Liang, Jie He, Keping Xie
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (13): 2525–2539.
https://doi.org/10.1158/1078-0432.CCR-22-2757
Published: 05 July 2023
View article titled, Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Open the PDF for Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates in another window
Includes: Multimedia, Supplementary data
Journal Articles

Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors

Sarah Croessmann, Jonathan H. Sheehan, Kyung-min Lee, Gregory Sliwoski, Jie He, Rebecca Nagy, David Riddle, Ingrid A. Mayer, Justin M. Balko, Richard Lanman, Vincent A. Miller, Lewis C. Cantley, Jens Meiler, Carlos L. Arteaga
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1432.
https://doi.org/10.1158/1078-0432.CCR-18-4269
Published: 15 February 2019
View article titled, Correction: <em>PIK3CA</em> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors
Open the PDF for Correction: <em>PIK3CA</em> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors in another window
Journal Articles

Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer

Sarah Croessmann, Luigi Formisano, Lisa N. Kinch, Paula I. Gonzalez-Ericsson, Dhivya R. Sudhan, Rebecca J. Nagy, Aju Mathew, Eric H. Bernicker, Massimo Cristofanilli, Jie He, Richard E. Cutler, Jr, Alshad S. Lalani, Vincent A. Miller, Richard B. Lanman, Nick V. Grishin, Carlos L. Arteaga
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 277–289.
https://doi.org/10.1158/1078-0432.CCR-18-1544
Published: 03 January 2019
View article titled, Combined Blockade of Activating <em>ERBB2</em> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer
Open the PDF for Combined Blockade of Activating <em>ERBB2</em> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling

Yanhua Tian, Zhijie Wang, Xiaohui Liu, Jianchun Duan, Guoshuang Feng, Yuxin Yin, Jin Gu, Zhaoli Chen, Shugeng Gao, Hua Bai, Rui Wan, Jun Jiang, Jia Liu, Cong Zhang, Di Wang, Jiefei Han, Xue Zhang, Liangliang Cai, Jie He, Jie Wang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (9): 2100–2109.
https://doi.org/10.1158/1078-0432.CCR-17-2855
Published: 30 April 2018
View article titled, Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling
Open the PDF for Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling in another window
Includes: Supplementary data
Journal Articles

PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K α Inhibitors

Sarah Croessmann, Jonathan H. Sheehan, Kyung-min Lee, Gregory Sliwoski, Jie He, Rebecca Nagy, David Riddle, Ingrid A. Mayer, Justin M. Balko, Richard Lanman, Vincent A. Miller, Lewis C. Cantley, Jens Meiler, Carlos L. Arteaga
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (6): 1426–1435.
https://doi.org/10.1158/1078-0432.CCR-17-2141
Published: 14 March 2018
View article titled, <em>PIK3CA</em> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K α Inhibitors
Open the PDF for <em>PIK3CA</em> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K α Inhibitors in another window
Includes: Supplementary data
Journal Articles

A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma

Jeffrey S. Ross, Kai Wang, Laurie M. Gay, Rami N. Al-Rohil, Tipu Nazeer, Christine E. Sheehan, Timothy A. Jennings, Geoff A. Otto, Amy Donahue, Jie He, Gary Palmer, Siraj Ali, Michelle Nahas, Geneva Young, Elaine LaBrecque, Garrett Frampton, Rachel Erlich, John A. Curran, Kristina Brennan, Sean R. Downing, Roman Yelensky, Doron Lipson, Matthew Hawryluk, Vincent A. Miller, Philip J. Stephens
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (1): 68–75.
https://doi.org/10.1158/1078-0432.CCR-13-1992
Published: 05 January 2014
View article titled, A High Frequency of Activating Extracellular Domain <em>ERBB2</em> (<em>HER2</em>) Mutation in Micropapillary Urothelial Carcinoma
Open the PDF for A High Frequency of Activating Extracellular Domain <em>ERBB2</em> (<em>HER2</em>) Mutation in Micropapillary Urothelial Carcinoma in another window
Includes: Supplementary data
Journal Articles

Isocitrate Dehydrogenase 1 Is a Novel Plasma Biomarker for the Diagnosis of Non–Small Cell Lung Cancer

Nan Sun, Zhaoli Chen, Fengwei Tan, Baihua Zhang, Ran Yao, Chengcheng Zhou, Jiagen Li, Yibo Gao, Ziyuan Liu, Xiaogang Tan, Fang Zhou, Max Y.F He, Kang Shao, Ning Li, Bin Qiu, Jian Sun, Yue Yu, Suya Wang, Yuda Zhao, Xuejiao Shi, Jie He
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (18): 5136–5145.
https://doi.org/10.1158/1078-0432.CCR-13-0046
Published: 16 September 2013
View article titled, Isocitrate Dehydrogenase 1 Is a Novel Plasma Biomarker for the Diagnosis of Non–Small Cell Lung Cancer
Open the PDF for Isocitrate Dehydrogenase 1 Is a Novel Plasma Biomarker for the Diagnosis of Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Relapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations

Jeffrey S. Ross, Kai Wang, Christine E. Sheehan, Ann B. Boguniewicz, Geoff Otto, Sean R. Downing, James Sun, Jie He, John A. Curran, Siraj Ali, Roman Yelensky, Doron Lipson, Gary Palmer, Vincent A. Miller, Philip J. Stephens
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (10): 2668–2676.
https://doi.org/10.1158/1078-0432.CCR-13-0295
Published: 12 May 2013
View article titled, Relapsed Classic E-Cadherin (<em>CDH1</em>)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of <em>HER2</em> (<em>ERBB2</em>) Gene Mutations
Open the PDF for Relapsed Classic E-Cadherin (<em>CDH1</em>)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of <em>HER2</em> (<em>ERBB2</em>) Gene Mutations in another window
Includes: Supplementary data
Journal Articles

A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis

Xiaogang Tan, Wenyan Qin, Liang Zhang, Jie Hang, Baozhong Li, Cuiyan Zhang, Junting Wan, Fang Zhou, Kang Shao, Yimin Sun, Jianping Wu, Xun Zhang, Bin Qiu, Ning Li, Susheng Shi, Xiaoli Feng, Shouhua Zhao, Zhen Wang, Xiaohong Zhao, Zhaoli Chen, Keith Mitchelson, Jing Cheng, Yong Guo, Jie He
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6802–6811.
https://doi.org/10.1158/1078-0432.CCR-11-0419
Published: 31 October 2011
View article titled, A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Open the PDF for A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis in another window
Includes: Supplementary data